Qingyi Shi
Ningbo, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
BLyS/APRIL dual inhibition for systemic sclerosis: a single-centre, single-arm, open-label clinical trial of telitacicept.
Journal: Clinical and experimental rheumatology
Published: August 15, 2025
Cefepime, not Piperacillin/Tazobactam use, for empirical treatment of bloodstream infections caused by Enterobacter spp.: Results from a population pharmacokinetic/pharmacodynamic analysis.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 22, 2022
Acquisition of the mcr-1 Gene Lowers the Target Mutation to Impede the Evolution of a High-Level Colistin-Resistant Mutant in Escherichia coli.
Journal: Infection and drug resistance
Published: June 14, 2021
Clinical and Bacterial Characteristics of Klebsiella pneumoniae Affecting 30-Day Mortality in Patients With Bloodstream Infection.
Journal: Frontiers in cellular and infection microbiology
Published: March 31, 2021
Optimal empiric treatment for KPC-2-producing Klebsiella pneumoniae infections in critically ill patients with normal or decreased renal function using Monte Carlo simulation.
Journal: BMC infectious diseases
Published: January 08, 2021
Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China.
Journal: Journal of global antimicrobial resistance
Published: November 26, 2020
Epidemiology and risk factors of infective endocarditis in a tertiary hospital in China from 2007 to 2016.
Journal: BMC infectious diseases
Published: February 25, 2020
The clinical features and prognosis of infective endocarditis in the elderly from 2007 to 2016 in a tertiary hospital in China.
Journal: BMC infectious diseases
Published: June 22, 2019
A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections.
Journal: Antimicrobial resistance and infection control
Published: December 05, 2018
A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections.
Journal: Journal of global antimicrobial resistance
Published: November 30, 2018
Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data.
Journal: Infection and drug resistance
Published: November 07, 2018
In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae.
Journal: Infection and drug resistance
Published: May 08, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026